Time: Lindsey Wang, researcher at the School of Medicine, discussed new research showing that weight-loss drugs, including Ozempic, are linked to a lower risk of cancer. “This is very significant because usually when you get these cancers, you have a poor prognosis,” said Wang, noting that she conducted the research under the guidance of Distinguished University Professor Nathan Berger, who died last month at the age of 83.
